A Cluster Controlled Trial Comparing Three Methods of Disseminating Practice Guidelines for Children With Croup
3 other identifiers
interventional
N/A
0 countries
N/A
Brief Summary
The purpose of this study is to identify, from a societal perspective, the costs and associated benefits of three strategies for disseminating and implementing a practice guideline that addresses the management of croup.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2000
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2000
CompletedFirst Submitted
Initial submission to the registry
September 2, 2005
CompletedFirst Posted
Study publicly available on registry
September 7, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2006
CompletedNovember 29, 2005
September 1, 2005
September 2, 2005
November 28, 2005
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of hospital days per 1,000 disease episodes
Secondary Outcomes (4)
Proportion of patients treated in the ED and hospital with a corticosteroid.
Proportion of patients evaluated in ED for at least three hours after treatment with corticosteroids before the decision to admit to hospital is made.
Time to treatment with corticosteroids in both ED and hospital patients.
An economic analysis conducted from a societal perspective with costs classified as either payer (costs born by the province) or non-payer (costs born by individuals or the families of children with croup).
Interventions
Eligibility Criteria
You may qualify if:
- Alberta hospitals were rank ordered based on the number of disease episodes and rates of hospitalization for a six-year period. We then approached in this order each of the hospital administrators and clinical staff for permission to include their hospital in our study until a total of 24 hospitals consented
You may not qualify if:
- Refusal by hospital staff to participate in this trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David W Johnson, MD
University of Calgary
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- ECT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
September 2, 2005
First Posted
September 7, 2005
Study Start
September 1, 2000
Study Completion
March 1, 2006
Last Updated
November 29, 2005
Record last verified: 2005-09